Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to 0.1%.

  • Amphastar Pharmaceuticals' Return on Invested Capital fell 600.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.15% for FY2024, which is 400.0% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Return on Invested Capital is 0.1%, which was down 600.0% from 0.12% recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Invested Capital registered a high of 0.17% during Q2 2024, and its lowest value of 0.01% during Q1 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Return on Invested Capital value was 0.13% (recorded in 2022), while the average stood at 0.12%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first surged by 1100bps in 2022, then plummeted by -600bps in 2025.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Return on Invested Capital stood at 0.1% in 2021, then rose by 22bps to 0.13% in 2022, then rose by 21bps to 0.15% in 2023, then fell by -5bps to 0.15% in 2024, then plummeted by -34bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.12% for Q2 2025, and 0.13% during Q1 2025.